GAO Comes Down On Meaningful Use Program

The Government Accountability Office has recently raised an alarm that the meaningful use incentive program might not be all that it’s cracked up to be.

The controversy has swirled around clinical quality reporting, with many providers struggling to do as required under meaningful use Stage 2.

In a new report, the GAO said “reliability issues persist,” when it comes to HHS’s ability to use the clinical quality measures (CQMs) collected in certified EHRs for quality measurement activities.

For example, different providers may report CQMs based on and tested to different requirements depending on whether their EHRs have incorporated technical updates.